dc.creatorGazzaniga, Silvina
dc.creatorBravo, Alicia I.
dc.creatorGuglielmotti, Angelo
dc.creatorVan Rooijen, Nico
dc.creatorMaschi, Fabricio Alejandro
dc.creatorVecchi, Annunciata
dc.creatorMantovani, Alberto
dc.creatorMordoh, José
dc.creatorWainstok, Rosa
dc.date2007
dc.date2019-10-10T15:26:31Z
dc.identifierhttp://sedici.unlp.edu.ar/handle/10915/83061
dc.identifierissn:0022-202X
dc.descriptionChemokines such as monocyte chemoattractant protein (MCP)-1 are key agonists that attract macrophages to tumors. In melanoma, it has been previously shown that variable levels of MCP-1/CCL2 appear to correlate with infiltrating macrophages and tumor fate, with low to intermediate levels of the chemokine contributing to melanoma development. To work under such conditions, a poorly tumorigenic human melanoma cell line was transfected with an expression vector encoding MCP-1. We found that M2 macrophages are associated to MCP-1<SUP>+</SUP> tumors, triggering a profuse vascular network. To target the protumoral macrophages recruitment and reverting tumor growth promotion, clodronate-laden liposomes (Clod-Lip) or bindarit were administered to melanoma-bearing mice. Macrophage depletion after Clod-Lip treatment induced development of smaller tumors than in untreated mice. Immunohistochemical analysis with an anti-CD31 antibody revealed scarce vascular structures mainly characterized by narrow vascular lights. Pharmacological inhibition of MCP-1 with bindarit also reduced tumor growth and macrophage recruitment, rendering necrotic tumor masses. We suggest that bindarit or Clod-Lip abrogates protumoral-associated macrophages in human melanoma xenografts and could be considered as complementary approaches to antiangiogenic therapy.
dc.descriptionFacultad de Ciencias Veterinarias
dc.formatapplication/pdf
dc.format2031-2041
dc.languageen
dc.rightshttp://creativecommons.org/licenses/by-nc-sa/4.0/
dc.rightsCreative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0)
dc.subjectCiencias Veterinarias
dc.subjectCiencias Médicas
dc.subjectmelanoma
dc.subjecttumor
dc.titleTargeting tumor-associated macrophages and inhibition of MCP-1 reduce angiogenesis and tumor growth in a human melanoma xenograft
dc.typeArticulo
dc.typeArticulo


Este ítem pertenece a la siguiente institución